Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
The Readout

Moderna makes more money & biotech bets on the Super Bowl

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Feb. 2, 2018

Reprints
The READOUT
Alex Hogan/STAT

The Readout for February 02, 2018

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Novartis drug reduces breast cancer recurrence, but experts may…
Novartis drug reduces breast cancer recurrence, but experts may debate results
Insurance alone didn’t guarantee adherence to Ozempic, study finds
Insurance alone didn’t guarantee adherence to Ozempic, study finds
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories